C12N 9/104
Aminoacyltransferases
Official title: {Aminoacyltransferases (2.3.2)}
C12N9/104 (Aminoacyltransferases) appears on 269 US grants and 498 published applications in this corpus.
Search patents in C12N- Granted patents
- 269
- Published applications
- 498
- Assignees
- 296
- Inventors
- 1,340
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 2 | 0 |
| 1982 | 2 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 3 | 0 |
| 1992 | 5 | 0 |
| 1993 | 2 | 0 |
| 1994 | 0 | 0 |
| 1995 | 3 | 0 |
| 1996 | 4 | 0 |
| 1997 | 9 | 0 |
| 1998 | 9 | 0 |
| 1999 | 4 | 0 |
| 2000 | 8 | 0 |
| 2001 | 8 | 0 |
| 2002 | 8 | 8 |
| 2003 | 3 | 13 |
| 2004 | 5 | 9 |
| 2005 | 4 | 6 |
| 2006 | 4 | 8 |
| 2007 | 4 | 7 |
| 2008 | 2 | 8 |
| 2009 | 5 | 11 |
| 2010 | 5 | 17 |
| 2011 | 3 | 8 |
| 2012 | 8 | 13 |
| 2013 | 5 | 10 |
| 2014 | 7 | 9 |
| 2015 | 8 | 14 |
| 2016 | 10 | 8 |
| 2017 | 9 | 12 |
| 2018 | 5 | 19 |
| 2019 | 9 | 31 |
| 2020 | 11 | 28 |
| 2021 | 13 | 26 |
| 2022 | 17 | 41 |
| 2023 | 11 | 53 |
| 2024 | 19 | 47 |
| 2025 | 18 | 56 |
| 2026 | 12 | 36 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Compositions and methods for genetically-encoded high voltage-activated calcium channel blockers using engineered ubiquitin ligases6 Oct 2026US 12,753,228 B2The Trustees of Columbia University in the City of New York
- Modified UBE3A gene for a gene therapy approach for Angelman syndrome15 Sep 2026US 12,734,250 B2University of South Florida
- Immobilized proteases for activation of the zymogen form of transglutaminase25 Aug 2026US 12,716,059 B2Curie Co. Inc.
- Biodegradable textile fibers with inherent color and properties18 Aug 2026US 12,709,640 B2The Trustees of Columbia University in the City of New York
- Modified transglutaminase19 May 2026US 12,630,807 B2Amano Enzyme Inc.
- Polymerized hemoglobins and related compounds and methods24 Sep 2026US 2026/0285943 A1The Regents of the University of California
- Fusion proteins for improved gene editing24 Sep 2026US 2026/0286397 A1New York Genome Center, Inc.
- Enzyme preparation for cheese analog17 Sep 2026US 2026/0275320 A1Ajinomoto Co., Inc.
- Modified transglutaminase10 Sep 2026US 2026/0265707 A1Amano Enzyme Inc.
- Itch mutants for the treatment of memory and learning defects3 Sep 2026US 2026/0258444 A1National Institute of Immunology
Most cited
By later US patents
- Hemostatic agent270US 4,655,211 AUnitika Ltd. · 1987
- Biological adhesive composition and method of promoting adhesion between tissue surfaces142US 5,549,904 AOrthogene, Inc. · 1996
- Blood coagulation factors and process for their manufacture135US 4,297,344 ABehringwerke Aktiengesellschaft · 1981
- Transgultaminase111US 5,156,956 AAjinomoto Co., Inc. · 1992
- Pancreatic cancer targets and uses thereof104US 7,473,531 B1Colora Corporation · 2009